Ophthalmology

 

Sanoptis targets Spain for expansion

Sanoptis, Germany’s second largest ophthalmology group by revenue, is looking to expand in Spain, and beyond, and looking at targets to buy.

MidEuropa buys Optegra

UK, Czechia and Poland-based ophthalmology company Optegra has found a buyer - PE firm MidEuropa has reached a definitive agreement to acquire a majority stake while management and current owners H2 will retain minority stakes.

Optegra sale on hold

HBI understands from multiple sources that the sale of UK-based ophthalmology group Optegra is on hold.

Optegra for sale

UK-based ophthalmology group Optegra is for sale, with three groups through to the second round. HBI speaks with three sources to find out more.

Interview: Paresh Patel, CEO, OCL Vision

HBI chats with Paresh Patel, the new CEO of UK-based OCL Vision and former MD of UK, Czechia and Poland-based ophthalmology platform Optegra, about his new role, and the ophthalmology market in general.

Indian M&A roundup

Indian health care is seeing a flurry of activity. Evercare-owned Care Hospitals is reportedly up for sale in India, while IHH Healthcare Bhd has expressed renewed interest in India after the Indian Supreme Court passed judgement in relation to its contentious dealings with Fortis. Meantime, the largest shareholder in India's second largest eye hospital has sold its stake.

Veonet buys in Spain, looks abroad for expansion

HBI hears exclusively that large Germany-based ophthalmology platform Veonet is buying in Spain, and turning its attention generally to opportunities outside its domestic market.

HBI 2022: Panel sees a rosy future for ophthalmology

Ophthalmology continues to be a big area of investor interest, with considerable scope for consolidation in both healthcare services and also medical devices. As governments in the UK, Finland and parts of Eastern Europe in particular continue to increase outsourcing, the potential to unlock additional private pay services is increasing, and upselling of more complex lenses is on the rise. An expert panel convened at HBI 2022 to discuss the opportunities and challenges in the post-pandemic landscape.

Find Us